BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 33685425)

  • 1. Albumin-to-alkaline phosphatase ratio as a promising indicator of prognosis in human cancers: is it possible?
    An L; Yin WT; Sun DW
    BMC Cancer; 2021 Mar; 21(1):247. PubMed ID: 33685425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Pretreatment Albumin-to-Alkaline Phosphatase Ratio in Cancer: A Meta-Analysis.
    Xie H; Wei L; Tang S; Gan J
    Biomed Res Int; 2020; 2020():6661097. PubMed ID: 33376729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic effect of pretreatment albumin-to-alkaline phosphatase ratio in human cancers: A meta-analysis.
    Guo X; Zou Q; Yan J; Zhen X; Gu H
    PLoS One; 2020; 15(8):e0237793. PubMed ID: 32822383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic effect of albumin-to-alkaline phosphatase ratio on patients with hepatocellular carcinoma: a systematic review and meta-analysis.
    Zhang X; Xin Y; Chen Y; Zhou X
    Sci Rep; 2023 Jan; 13(1):1808. PubMed ID: 36720974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment albumin-to-alkaline phosphatase ratio as a prognostic indicator in solid cancers: A meta-analysis with trial sequential analysis.
    Tian G; Li G; Guan L; Yang Y; Li N
    Int J Surg; 2020 Sep; 81():66-73. PubMed ID: 32745716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Prognostic Value of Albumin-to-Alkaline Phosphatase Ratio before Radical Radiotherapy in Patients with Non-metastatic Nasopharyngeal Carcinoma: A Propensity Score Matching Analysis.
    Kim JS; Keam B; Heo DS; Han DH; Rhee CS; Kim JH; Jung KC; Wu HG
    Cancer Res Treat; 2019 Oct; 51(4):1313-1323. PubMed ID: 30699498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of pretreatment albumin-to-alkaline phosphatase ratio for overall survival for patients with advanced non-small cell lung cancer.
    Zhou S; Jiang W; Wang H; Wei N; Yu Q
    Cancer Med; 2020 Sep; 9(17):6268-6280. PubMed ID: 32691996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of dynamic albumin-to-alkaline phosphatase ratio in limited stage small-cell lung cancer.
    Li X; Li B; Zeng H; Wang S; Sun X; Yu Y; Wang L; Yu J
    Future Oncol; 2019 Mar; 15(9):995-1006. PubMed ID: 30644319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical role of pretreatment albumin-to-alkaline phosphatase ratio in lung cancer: a meta-analysis.
    Yang Y; Wang Y; Li X; Xie X
    Sci Rep; 2024 Jan; 14(1):1166. PubMed ID: 38216656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albumin-to-alkaline phosphatase ratio as a novel prognostic indicator for patients undergoing minimally invasive lung cancer surgery: Propensity score matching analysis using a prospective database.
    Li SJ; Lv WY; Du H; Li YJ; Zhang WB; Che GW; Liu LX
    Int J Surg; 2019 Sep; 69():32-42. PubMed ID: 31319230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Albumin-to-alkaline phosphatase ratio serves as a prognostic indicator in unresectable pancreatic ductal adenocarcinoma: a propensity score matching analysis.
    Zhang K; Dong S; Jing YH; Gao HF; Chen LY; Hua YQ; Chen H; Chen Z
    BMC Cancer; 2020 Jun; 20(1):541. PubMed ID: 32517802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of the preoperative albumin to alkaline phosphatase ratio in patients with non-small cell lung cancer after surgery.
    Zhang L; Zhang H; Yue D; Wei W; Chen Y; Zhao X; Zhu J; Zhang B; Zhang Z; Wang C
    Thorac Cancer; 2019 Jul; 10(7):1581-1589. PubMed ID: 31161711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prognostic Value of Preoperative Albumin-to-Alkaline Phosphatase Ratio on Survival Outcome for Patients With Locally Advanced Oral Squamous Cell Carcinoma.
    Tsai MH; Chuang HC; Lin YT; Yang KL; Lu H; Huang TL; Tsai WL; Su YY; Fang FM
    Technol Cancer Res Treat; 2022; 21():15330338221141254. PubMed ID: 36426570
    [No Abstract]   [Full Text] [Related]  

  • 14. Albumin-to-Alkaline Phosphatase Ratio: Does It Predict Survival in Grade 1 and Grade 2 Neuroendocrine Tumors?
    Acikgoz Y; Bal O; Dogan M
    Pancreas; 2021 Jan; 50(1):111-117. PubMed ID: 33370032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albumin-fibrinogen ratio and fibrinogen-prealbumin ratio as promising prognostic markers for cancers: an updated meta-analysis.
    Sun DW; An L; Lv GY
    World J Surg Oncol; 2020 Jan; 18(1):9. PubMed ID: 31931816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic significance of Albumin-to-Alkaline Phosphatase Ratio in upper tract urothelial carcinoma.
    Tan P; Xie N; Ai J; Xu H; Xu H; Liu L; Yang L; Wei Q
    Sci Rep; 2018 Aug; 8(1):12311. PubMed ID: 30120312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of serum albumin-to-alkaline phosphatase ratio in cervical cancer patients treated with definitive chemoradiotherapy.
    Onal C; Gultekin M; Yavas G; Oymak E; Yuce Sari S; Guler OC; Yigit E; Yildiz F
    J Obstet Gynaecol; 2022 Aug; 42(6):2426-2432. PubMed ID: 35653776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Albumin-to-alkaline phosphatase ratio as a predictor of tumor recurrence and prognosis in patients with early-stage hepatocellular carcinoma undergoing radiofrequency ablation as initial therapy.
    Zhang F; Lu SX; Hu KS; Gan YH; Chen Y; Ge NL; Yang BW; Zhang L; Chen RX; Ren ZG; Yin X
    Int J Hyperthermia; 2021; 38(1):1-10. PubMed ID: 33400889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low albumin-to-alkaline phosphatase ratio is associated with inferior prognosis in patients with head and neck cancer underwent concurrent chemoradiation: A propensity score-matched analysis.
    Kim D; Ki Y; Kim W; Park D; Joo J; Jeon H; Nam J
    J Cancer Res Ther; 2023; 19(5):1340-1344. PubMed ID: 37787305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of preoperative albumin-to-alkaline phosphatase ratio in patients with surgically treated urological cancer: a systematic review and meta-analysis.
    Ren S; Wang H; Yang B; Zheng Y; Ou Y; Bao Y; Mao Y; Feng Y
    Front Oncol; 2023; 13():1236167. PubMed ID: 38023164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.